Standard Biotools (LAB) Other Working Capital Changes (2017 - 2026)

Standard Biotools (LAB) has reported Other Working Capital Changes for 17 consecutive years, with -$4.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 183.54% year-over-year to -$4.4 million in Q2 2026; TTM through Jun 2026 was -$6.2 million, a 49.39% increase from a year earlier, with the FY2025 full-year figure at -$6.4 million, down 9.41% from the prior year.
• Other Working Capital Changes was -$4.4 million for Q2 2026 at Standard Biotools, down from $1.6 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $804000.0 in Q1 2023 and troughed at -$29.9 million in Q1 2026.
• A 5-year average of -$2.1 million and a median of -$549000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes sank 1018.27% in 2023 and jumped 638.59% in 2024, its largest moves.
• Over 5 years, Other Working Capital Changes stood at -$3.3 million in 2022, then soared by 70.81% to -$957000.0 in 2023, then tumbled by 51.41% to -$1.4 million in 2024, then declined by 15.73% to -$1.7 million in 2025, then tumbled by 163.92% to -$4.4 million in 2026.
• The last three Other Working Capital Changes figures came in at -$4.4 million (Q2 2026), $1.6 million (Q1 2026), and -$1.7 million (Q4 2025), per Business Quant data.